webinar register page

CCF Webinar Series: An interesting new study at NCI: Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Biliary Tract Carcinoma
Presented by: Cecilia Monge, M.D., M.P.H., FACP Dr. Cecilia Monge specializes in first-in-human and early-phase clinical studies of gastrointestinal (GI) malignancies, including liver cancer, biliary tract cancer, colorectal cancer and pancreatic cancer.

Join us to learn about a new clinical trial at the National Cancer Institute.

Jul 22, 2021 02:00 PM in Mountain Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Rick Pollock.